后房型虹膜夹持人工晶体联合玻璃体切割术治疗无晶状体眼的多中心审计
该多中心、全国性审计纳入325眼(325例患者),评估后房型虹膜夹持人工晶体植入联合玻璃体切割术治疗无晶状体眼或人工晶体脱位的结果与安全性。12个月随访时,最终视力≤0.3 logMAR(≥20/40 Snellen)的累积概率为75.6%,黄斑水肿累积概率为20.5%,需角膜移植者为2.8%(9/325)。
要点
- 12个月时最终视力≤0.3 logMAR的累积概率为75.6%。
- 12个月时黄斑水肿累积概率为20.5%,复杂白内障手术眼高于晶体脱位眼(26% vs. 16.7%,P=0.04)。
- 需青光眼手术者占4.3%(14/325),需角膜移植者占2.8%(9/325)。
核心结论
- 后房型虹膜夹持人工晶体技术治疗无晶状体眼或人工晶体脱位在真实世界场景中提供了临床结局数据,可用于患者咨询和术前讨论。
研究设计与样本
- 多中心、全国性审计,纳入325眼(325例患者),收集人口学、手术细节和并发症数据。
- 术后1、3、6、12个月评估视力、眼压和光学相干断层扫描测量的黄斑中心凹厚度。
- 采用Kaplan-Meier曲线评估术后视力、眼压水平、黄斑水肿发生和角膜失代偿的累积概率。
主要发现
- 12个月随访时最终视力≤0.3 logMAR(≥20/40 Snellen)的累积概率为75.6%。
- 12个月时眼压>21、≥25和≥30 mmHg的概率分别为48.1%、33.1%和19.0%,使用降眼压滴眼液的概率为50.9%。
- 12个月时黄斑水肿累积概率为20.5%,复杂白内障手术眼高于人工晶体脱位眼(26% vs. 16.7%,P=0.04)。
- 需青光眼手术者占4.3%(14/325),需角膜移植者占2.8%(9/325)。
临床怎么用
- 该真实世界数据可用于无晶状体眼或人工晶体脱位患者术前咨询,告知视力预后、眼压升高和黄斑水肿等风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the outcomes and safety of retropupillary iris-claw intraocular lens implantation and associated pars plana vitrectomy. METHODS: Multicenter, national audit of 325 eyes (325 patients). Demographics, surgical details, and complications are described. Visual acuity, intraocular pressure, and central retinal thickness assessed by optical coherence tomography were collected at 1, 3, 6, and 12 months after surgery. Kaplan-Meier curves were created to assess the cumulative probability of postoperative visual acuity and intraocular pressure levels, macular edema development, and corneal decompensation. RESULTS: The cumulative probability of the final visual acuity ≤0.3 logarithm of the minimum angle of resolution (≥20/40 Snellen) was 75.6% at 12-month follow-up. The probability of intraocular pressure >21, ≥25, and ≥30 mmHg was 48.1%, 33.1%, and 19.0%, and the probability of intraocular pressure-lowering drops was 50.9% at 12 months. Glaucoma surgery was required in 4.3% of the eyes (14/325). The cumulative probability of macular edema was 20.5% at 12 months and was greater in complicated cataract surgery than in intraocular lens-luxation eyes (26% vs. 16.7%, P = 0.04). Corneal transplantation was required in 2.8% of the eyes (9/325). CONCLUSION: This study on 325 eyes with aphakia or intraocular lens dislocation managed with the retropupillary iris-claw intraocular lens technique provides clinical outcomes in a real-world scenario, reporting relevant data for patient counseling and preoperative discussions.
引用
- Bernal-Morales C, Hernández-Martínez A, Navarro-Angulo MJ, et al. RETROPUPILLARY IRIS-CLAW INTRAOCULAR LENS AND PARS PLANA VITRECTOMY IN APHAKIA MANAGEMENT: A National Multicenter Audit. Retina. 2021. PMID: 33675333. doi:10.1097/IAE.0000000000003161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。